InvestSMART

Imugene Limited (ASX: IMU) - Announcements

- Current share price for IMU : $0.083

ASX company news and announcements for Imugene Limited (IMU) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Imugene Limited (IMU) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Imugene Limited (IMU), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Imugene Limited (IMU)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$41 Preliminary Final Report 29 Aug 2013 1:10PM $0.006 $0.083 risen by 1,283.33%
$41 Vitamin D development program at commercialisation stage 8 Aug 2013 8:55AM $0.008 $0.083 risen by 937.50%
$41 Japanese patent for novel drug delivery technology 7 Aug 2013 9:16AM $0.005 $0.083 risen by 1,560%
$41 Appendix 4C - quarterly 29 Jul 2013 1:11PM $0.005 $0.083 risen by 1,560%
$41 Progress on Linguet Ibuprofen formulation 2 Jul 2013 8:54AM $0.004 $0.083 risen by 1,975%
$41 Share Purchase Plan Results & $181K R&D Refund 4 Jun 2013 9:07AM $0.006 $0.083 risen by 1,283.33%
$41 Imugene progresses Vitamin D development program 23 May 2013 9:02AM $0.006 $0.083 risen by 1,283.33%
$41 Share Purchase Plan - Offer Document 30 Apr 2013 9:10AM $0.010 $0.083 risen by 730%
$41 Share Purchase Plan 30 Apr 2013 9:01AM $0.010 $0.083 risen by 730%
$41 Imugene granted Chinese patent 30 Apr 2013 8:18AM $0.010 $0.083 risen by 730%
$41 Appendix 4C - quarterly 29 Apr 2013 4:35PM $0.008 $0.083 risen by 937.50%
$41 Imugene to be awarded Japanese patent 5 Mar 2013 8:32AM $0.010 $0.083 risen by 730%
$41 Half Year Financial Results 28 Feb 2013 3:23PM $0.009 $0.083 risen by 822.22%
$41 Half Yearly Report and Accounts 28 Feb 2013 3:23PM $0.009 $0.083 risen by 822.22%
$41 Reply to Query - Appendix 4C 11 Feb 2013 10:16AM $0.010 $0.083 risen by 730%
$41 Appendix 4C - quarterly 31 Jan 2013 6:35PM $0.014 $0.083 risen by 492.86%
$41 Appendix 4C - quarterly 31 Oct 2012 5:27PM $0.013 $0.083 risen by 538.46%
$41 Changes to the Board of Directors 31 Oct 2012 8:55AM $0.013 $0.083 risen by 538.46%
$41 Imugene announces details of drug delivery program 20 Sep 2012 11:26AM $0.019 $0.083 risen by 336.84%
$41 Response to ASX Query 12 Sep 2012 5:51PM $0.014 $0.083 risen by 492.86%
$41 Appendix 4E and Financial Report 31 Aug 2012 6:42PM $0.012 $0.083 risen by 591.67%
$41 Board Appointment & New Direction 1 Aug 2012 12:02PM $0.014 $0.083 risen by 492.86%
$41 Acquisition Completed, Board Changes & Share Placement 31 Jul 2012 4:36PM $0.014 $0.083 risen by 492.86%
$41 Quarterly Shareholder Update & Appendix 4C 31 Jul 2012 2:08PM $0.014 $0.083 risen by 492.86%
$41 Acquisition of Drug Delivery Platform and Share Placement 1 May 2012 7:21PM $0.016 $0.083 risen by 418.75%

1051 - 1075 of 1186 results

Page 43 of 48

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.